{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:44:52Z","timestamp":1770993892245,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11030-013-9422-5","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T11:10:33Z","timestamp":1358853033000},"page":"123-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Exploration of structural and physicochemical requirements and search of virtual hits for aminopeptidase N inhibitors"],"prefix":"10.1007","volume":"17","author":[{"given":"Amit K.","family":"Halder","sequence":"first","affiliation":[]},{"given":"Achintya","family":"Saha","sequence":"additional","affiliation":[]},{"given":"Tarun","family":"Jha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"9422_CR1","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.2174\/092986711797535155","volume":"18","author":"X Zhang","year":"2011","unstructured":"Zhang X, Fang H, Zhang J, Yuan Y, Xu W (2011) Recent advances in aminopeptidase N (APN\/CD13) inhibitor research. Curr Med Chem 18:5011\u20135021. doi:10.2174\/092986711797535155","journal-title":"Curr Med Chem"},{"key":"9422_CR2","doi-asserted-by":"publisher","first-page":"33664","DOI":"10.1074\/jbc.M605203200","volume":"281","author":"K Ito","year":"2006","unstructured":"Ito K, Nakashima Y, Onohara Y, Takeo M, Nakashima K, Matsubara F (2006) Crystal structure of aminopeptidase N (proteobacterial alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition. J Biol Chem 281:33664\u201333676. doi:10.1074\/jbc.M605203200","journal-title":"J Biol Chem"},{"key":"9422_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/med.20044","volume":"26","author":"B Bauvois","year":"2006","unstructured":"Bauvois B, Dauzonne D (2006) Aminopeptidase-N\/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 26:88\u2013130. doi:10.1002\/med.20044","journal-title":"Med Res Rev"},{"key":"9422_CR4","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/art.10517","volume":"46","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Tani K, Hase K, Ogawa H, Huang L, Shinomiya F, Sone S (2002) CD13\/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 46:2330\u20132338. doi:10.1002\/art.10517","journal-title":"Arthritis Rheum"},{"key":"9422_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0090-1229(85)90147-3","volume":"37","author":"DA Hafler","year":"1985","unstructured":"Hafler DA, Hemler ME, Christenson L, Williams JM, Shapiro HM, Strom TB, Strominger JL, Weiner HL (1985) Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. Clin Immunol Immunopathol 37: 163\u2013171. doi:10.1016\/0090-1229(85)90147-3","journal-title":"Clin Immunol Immunopathol"},{"key":"9422_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/092986707780059571","volume":"14","author":"YP Luan","year":"2007","unstructured":"Luan YP, Xu WF (2007) The structure and main functions of aminopeptidase N. Curr Med Chem 14:639\u2013647. doi:10.2174\/092986707780059571","journal-title":"Curr Med Chem"},{"key":"9422_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1349-7006.2010.01826.x","volume":"102","author":"M Wickstrom","year":"2011","unstructured":"Wickstrom M, Larsson R, Nygren P, Gullbo J (2011) Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci 102:501\u2013508. doi:10.1111\/j.1349-7006.2010.01826.x","journal-title":"Cancer Sci"},{"key":"9422_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7164\/antibiotics.29.97","volume":"29","author":"H Umezawa","year":"1976","unstructured":"Umezawa H, Aoyagi T, Suda H, Hamada M, Takeushi T (1976) Bestatin an inhibitor of aminopeptidase B produced by actinomycetes. J Antibiotic 29:97\u201399. doi:10.7164\/antibiotics.29.97","journal-title":"J Antibiotic"},{"key":"9422_CR9","doi-asserted-by":"publisher","first-page":"36804","DOI":"10.1074\/jbc.M112.398842","volume":"287","author":"AHM Wong","year":"2012","unstructured":"Wong AHM, Zhou D, Rini JM (2012) The x-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing. J Biol Chem 287:36804\u201336813. doi:10.1074\/jbc.M112.398842","journal-title":"J Biol Chem"},{"key":"9422_CR10","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.ejmech.2007.12.020","volume":"43","author":"X-C Cheng","year":"2008","unstructured":"Cheng X-C, Wang Q, Fang H, Tang W, Xu W-F (2008) Design synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors. Eur J Med Chem 43: 2130\u20132139. doi:10.1016\/j.ejmech.2007.12.020","journal-title":"Eur J Med Chem"},{"key":"9422_CR11","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1016\/j.bmc.2008.04.027","volume":"16","author":"X-C Cheng","year":"2008","unstructured":"Cheng X-C, Wang Q, Fang H, Tang H, Xu W-F (2008) Design synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors. Bioorg Med Chem 16: 5398\u20135404. doi:10.1016\/j.bmc.2008.04.027","journal-title":"Bioorg Med Chem"},{"key":"9422_CR12","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.ejmech.2009.12.071","volume":"45","author":"Q Li","year":"2010","unstructured":"Li Q, Fang H, Wang X, Xu W (2010) Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors structure-based design chemistry and activity evaluation II. Eur J Med Chem 45:1618\u20131626. doi:10.1016\/j.ejmech.2009.12.071","journal-title":"Eur J Med Chem"},{"key":"9422_CR13","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.1016\/j.bmc.2011.07.008","volume":"19","author":"M Jia","year":"2011","unstructured":"Jia M, Yang K, Fang H, Xu Y, Sun S, Su L, Xu W (2011) Novel aminopeptidase N (APN\/CD13) inhibitors derived from chloramphenicol amine. Bioorg Med Chem 19:5190\u20135198. doi:10.1016\/j.bmc.2011.07.008","journal-title":"Bioorg Med Chem"},{"key":"9422_CR14","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1016\/j.bmc.2010.06.078","volume":"18","author":"X Zhang","year":"2010","unstructured":"Zhang X, Fang H, Zhu H, Wang X, Zhang L, Li M, Li Q, Yuan Y, Xu W (2010) Novel aminopeptidase N (APN\/CD13) inhibitors derived from 3-phenylalanylyl-N\u2019-substituted-26-piperidinedione. Bioorg Med Chem 18:5981\u20135987. doi:10.1016\/j.bmc.2010.06.078","journal-title":"Bioorg Med Chem"},{"key":"9422_CR15","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.1016\/j.bmc.2009.07.014","volume":"17","author":"Y Liu","year":"2009","unstructured":"Liu Y, Shang L, Fang H, Zhu H, Mu J, Wang Q, Wang X, Yuan Y, Xu W (2009) Design synthesis and preliminary studies of the activity of novel derivatives of N-cinnamoyl-l-aspartic acid as inhibitors of aminopeptidase N\/CD13. Bioorg Med Chem 17:7398\u20137404. doi:10.1016\/j.bmc.2009.07.014","journal-title":"Bioorg Med Chem"},{"key":"9422_CR16","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1016\/j.bmc.2009.03.017","volume":"17","author":"X Li","year":"2009","unstructured":"Li X, Wang Y, Wu J, Li Y, Wang Q, Xu W (2009) Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (part II). Bioorg Med Chem 17:3061\u20133071. doi:10.1016\/j.bmc.2009.03.017","journal-title":"Bioorg Med Chem"},{"key":"9422_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ardp.201100109","volume":"344","author":"X Li","year":"2011","unstructured":"Li X, Wang J, Zhang L, Xu W (2011) Design, synthesis and preliminary activity evaluation of novel peptidomimetics as aminopeptidase N\/CD13 inhibitors. Arch Pharm Chem Life Sci 344:494\u2013504. doi:10.1002\/ardp.201100109","journal-title":"Arch Pharm Chem Life Sci"},{"key":"9422_CR18","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1016\/j.bmc.2009.02.063","volume":"17","author":"X Li","year":"2009","unstructured":"Li X, Wang J, Li J, Wu J, Li Y, Zhu H, Fan R, Xu W (2009) Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I). Bioorg Med Chem 17:3053\u20133060. doi:10.1016\/j.bmc.2009.02.063","journal-title":"Bioorg Med Chem"},{"key":"9422_CR19","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.1016\/j.bmc.2008.07.073","volume":"16","author":"X-C Cheng","year":"2008","unstructured":"Cheng X-C, Wang Q, Fang H, Tang W, Xu W-F (2008) Synthesis of new sulfonyl derivatives as matrix metalloproteinase inhibitors. Bioorg Med Chem 16:7932\u20137938. doi:10.1016\/j.bmc.2008.07.073","journal-title":"Bioorg Med Chem"},{"key":"9422_CR20","unstructured":"http:\/\/www.bindingdb.org"},{"key":"9422_CR21","unstructured":"Accelrys Inc Discovery Studio 3.0 San Diego USA 2011"},{"key":"9422_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/jm010360c","volume":"45","author":"AK Debnath","year":"2002","unstructured":"Debnath AK (2002) Pharmacophore mapping of a series of 24-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase. J Med Chem 45:41\u201353. doi:10.1021\/jm010360c","journal-title":"J Med Chem"},{"key":"9422_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1747-0285.2011.01127.x","volume":"78","author":"S Thangapandian","year":"2011","unstructured":"Thangapandian S, John S, Sakkiah S, Lee KW (2011) Discovery of potential integrin VLA-4 antagonists using pharmacophore modeling virtual screening and molecular docking studies. Chem Biol Drug Des 78:289\u2013300. doi:10.1111\/j.1747-0285.2011.01127.x","journal-title":"Chem Biol Drug Des"},{"key":"9422_CR24","doi-asserted-by":"publisher","first-page":"17966","DOI":"10.1073\/pnas.1210123109","volume":"109","author":"L Chen","year":"2012","unstructured":"Chen L, Lin Y-L, Peng G, Li F (2012) Structural basis for multifunctional roles of mammalian aminopeptidase N. PNAS 109: 17966\u201317971. doi:10.1073\/pnas.1210123109","journal-title":"PNAS"},{"key":"9422_CR25","first-page":"193","volume-title":"Pharmacophore perception development and use in drug design","author":"FG Osman","year":"2000","unstructured":"Osman FG, Douglas RH (2000) Metric for analyzing hit lists and pharmacophores. In: Guner OF (ed) Pharmacophore perception development and use in drug design, 1st edn. International University Line La Jolla, San Diego, CA, pp 193\u2013210","edition":"1"},{"key":"9422_CR26","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin I-J, Bertrand H-O (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534\u20132547. doi:10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"9422_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"HJ Bohm","year":"1992","unstructured":"Bohm HJ (1992) The Computer Program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput-Aided Mol Des 6:61\u201378. doi:10.1007\/BF00124387","journal-title":"J Comput-Aided Mol Des"},{"key":"9422_CR28","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1021\/ci800143n","volume":"48","author":"P Prathipati","year":"2008","unstructured":"Prathipati P, Ma NL, Keller TH (2008) Global Bayesian models for the prioritization of antitubercular agents. J Chem Inf Model 48:2362\u20132370. doi:10.1021\/ci800143n","journal-title":"J Chem Inf Model"},{"key":"9422_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10822-011-9472-7","volume":"25","author":"J Lu","year":"2011","unstructured":"Lu J, Zheng M, Wang Y, Shen Q, Luo X, Jiang H, Chen K (2011) Fragment-based prediction of skin sensitization using recursive partitioning. J Comput Aided Mol Des 25:885\u2013893. doi:10.1007\/s10822-011-9472-7","journal-title":"J Comput Aided Mol Des"},{"key":"9422_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chemolab.2011.08.007","volume":"109","author":"PK Ojha","year":"2011","unstructured":"Ojha PK, Roy K (2011) Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chem Int Lab Sys 109:146\u2013161. doi:10.1016\/j.chemolab.2011.08.007","journal-title":"Chem Int Lab Sys"},{"key":"9422_CR31","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1021\/ci050049u","volume":"45","author":"S Li","year":"2005","unstructured":"Li S, Fedorowicz A, Singh H, Soderholm SC (2005) Application of the random forest method in studies of local lymph node assay based skin sensitization data. J Chem Inf Model 45:952\u2013964. doi:10.1021\/ci050049u","journal-title":"J Chem Inf Model"},{"key":"9422_CR32","doi-asserted-by":"publisher","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 23:3\u201325. doi:10.1016\/S0169-409X(96)00423-1","DOI":"10.1016\/S0169-409X(96)00423-1"},{"key":"9422_CR33","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. doi:10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"9422_CR34","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1021\/ci6004299","volume":"47","author":"SN Rao","year":"2007","unstructured":"Rao SN, Head MS, Kulkarni A, Lalonde JM (2007) Validation studies of the site-directed docking program LibDock. J Chem Inf Model 47:2159\u20132171. doi:10.1021\/ci6004299","journal-title":"J Chem Inf Model"},{"key":"9422_CR35","unstructured":"http:\/\/www.ccdc.cam.ac.uk\/products\/life_sciences\/gold"},{"key":"9422_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","volume":"245","author":"G Jones","year":"1995","unstructured":"Jones G, Willet P, Glen RC (1995) Molecular recognition of receptor sites using a genetic algorithm with a descriptor of desolvation. J Mol Biol 245:43\u201353. doi:10.1016\/S0022-2836(95)80037-9","journal-title":"J Mol Biol"},{"key":"9422_CR37","unstructured":"Glide ver 5.5 Schrodinger LLC, New York 2012"},{"key":"9422_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jcc.540070419","volume":"7","author":"AK Ghose","year":"1986","unstructured":"Ghose AK, Crippen G (1986) Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure\u2013activity relationships. I. Partition coefficient as a measure of hydrophobicity. J Comp Chem 7:565\u2013577. doi:10.1002\/jcc.540070419","journal-title":"J Comp Chem"},{"key":"9422_CR39","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.ejmech.2011.03.035","volume":"46","author":"S Thangapandian","year":"2011","unstructured":"Thangapandian S, John S, Sakkiah S, Lee KW (2011) Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches. Eur J Med Chem 46:2469\u20132476. doi:10.1016\/j.ejmech.2011.03.035","journal-title":"Eur J Med Chem"},{"key":"9422_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/1062936X.2010.501817","volume":"21","author":"S Saxena","year":"2010","unstructured":"Saxena S, Chaudhaery SS, Varshney K, Saxena AK (2010) Pharmacophore based virtual screening and docking studies of HSP90 inhibitors. SAR QSAR Env Res 21:445\u2013462. doi:10.1080\/1062936X.2010.501817","journal-title":"SAR QSAR Env Res"},{"key":"9422_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1423-0127-18-8","volume":"18","author":"S-H Lu","year":"2011","unstructured":"Lu S-H, Wu JW, Liu H-L, Zhao J-H, Liu K-T, Chuang C-K, Lin H-Y, Tsai W-B, Ho Y (2011) The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling virtual screening and docking studies. J Biomed Sci 18:8\u201313. doi:10.1186\/1423-0127-18-8","journal-title":"J Biomed Sci"},{"key":"9422_CR42","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-12-S1-S28","volume":"12","author":"S John","year":"2011","unstructured":"John S, Thangapandian S, Sakkiah S, Lee KW (2011) Potent bace-1 inhibitor design using pharmacophore modeling in silico screening and molecular docking studies. BMC Bioinformatics 12:S1\u2013S28. doi:10.1186\/1471-2105-12-S1-S28","journal-title":"BMC Bioinformatics"},{"key":"9422_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jmgm.2009.09.005","volume":"28","author":"MO Taha","year":"2010","unstructured":"Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G (2010) Pharmacophore and QSAR modeling of estrogen receptor $$\\beta $$ ligands and subsequent validation and in silico search for new hits. J Mol Graph Model 28:383\u2013400. doi: 10.1016\/j.jmgm.2009.09.005","journal-title":"J Mol Graph Model"},{"key":"9422_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jmgm.2007.07.002","volume":"26","author":"S Vadivelan","year":"2008","unstructured":"Vadivelan S, Sinha BN, Rambabu G, Boppanna K, Jagarlapudi (2008) Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new hits. J Mol Graph Model 26:935\u2013946. doi:10.1016\/j.jmgm.2007.07.002","journal-title":"J Mol Graph Model"},{"key":"9422_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/ci800386v","volume":"49","author":"RSK Vijayan","year":"2009","unstructured":"Vijayan RSK, Prabu M, Mascarenhas NM, Ghoshal N (2009) Hybrid structure-based virtual screening protocol for the identification of novel BACE1 Inhibitors. J Chem Inf Model 49:647\u2013657. doi:10.1021\/ci800386v","journal-title":"J Chem Inf Model"},{"key":"9422_CR46","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.ejmech.2011.04.018","volume":"46","author":"S Sakkiah","year":"2011","unstructured":"Sakkiah S, Thangapandian S, John S, Lee KW (2011) Pharmacophore based virtual screening molecular docking studies to design potent heat shock protein 90 inhibitors. Eur J Med Chem 46:2937\u20132947. doi:10.1016\/j.ejmech.2011.04.018","journal-title":"Eur J Med Chem"},{"key":"9422_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distino S, Wolber G, Langer T (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparison enrichment assessment and decoy selection: what can we learn from earlier mistakes? J Comput Aided Mol Des 22: 213\u2013228. doi:10.1007\/s10822-007-9163-6","journal-title":"J Comput Aided Mol Des"},{"key":"9422_CR48","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1021\/ci100368t","volume":"51","author":"MO Taha","year":"2011","unstructured":"Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S (2011) Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies. J Chem Inf Model 51:647\u2013669. doi:10.1021\/ci100368t","journal-title":"J Chem Inf Model"},{"key":"9422_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1021\/ci034289q","volume":"44","author":"ML Verdonk","year":"2004","unstructured":"Verdonk ML, Berdini V, Hartshorn MJ, Mooji WTM, Murray CW, Taylor RD, Watson P (2004) Virtual screening using protein\u2013ligand docking: avoiding artificial enrichment. J Chem Inf Comp Sci 44:793\u2013806. doi:10.1021\/ci034289q","journal-title":"J Chem Inf Comp Sci"},{"key":"9422_CR50","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/S0960-894X(03)00550-X","volume":"13","author":"M Flippo","year":"2003","unstructured":"Flippo M, Florent I, Grellier P, Sergheraert C, Deprez-Poulain P (2003) Design, synthesis and antimalarial activity of novel quinoline-based zinc metallo-aminopeptidase inhibitors. Bioorg Med Chem Lett 13:2659\u20132662. doi:10.1016\/S0960-894X(03)00550-X","journal-title":"Bioorg Med Chem Lett"},{"key":"9422_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1039\/c1md00210d","volume":"3","author":"MPA Sanders","year":"2012","unstructured":"Sanders MPA, McGuire R, Roumen L, de Esch IJP, de Vlieg J, Klomp JPG, de Graff C (2012) From the protein\u2019s perspective: the benefit and challenges of protein structure-based pharmacophore modeling. Med Chem Commun 3:28\u201338. doi:10.1039\/c1md00210d","journal-title":"Med Chem Commun"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-013-9422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-013-9422-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-013-9422-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-013-9422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:47:04Z","timestamp":1744170424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-013-9422-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9422"],"URL":"https:\/\/doi.org\/10.1007\/s11030-013-9422-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]},"assertion":[{"value":"10 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}